UB Paderborn / Katalog / Suche / in CDI

Focus on musculoskeletal health in women with bleeding disorders

Journal of Haemophilia Practice, 2022-11, Vol.9 (1), p.132-136

2022

Link zum Volltext

Verfügbarkeit prüfen

Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study

The Lancet (British edition), 2017-02, Vol.389 (10069), p.612-620

2017

Link zum Volltext

Verfügbarkeit prüfen

A randomized and double‐blind controlled trial evaluating the safety and efficacy of rituximab for warm auto‐immune hemolytic anemia in adults (the RAIHA study)

American journal of hematology, 2017-01, Vol.92 (1), p.23-27

2017

Link zum Volltext

Verfügbarkeit prüfen

Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis

Haematologica (Roma), 2021-04, Vol.106 (4), p.1182-1187

2021

Link zum Volltext

Verfügbarkeit prüfen

miR-346 controls release of TNF-α protein and stability of its mRNA in rheumatoid arthritis via tristetraprolin stabilization

PloS one, 2011, Vol.6 (5), p.e19827-e19827

2011

Link zum Volltext

Verfügbarkeit prüfen

Bruton's Tyrosine Kinase Is Involved in miR-346-Related Regulation of IL-18 Release by Lipopolysaccharide-Activated Rheumatoid Fibroblast-Like Synoviocytes

The Journal of immunology (1950), 2009-04, Vol.182 (8), p.5088-5097

2009

Link zum Volltext

Verfügbarkeit prüfen

Arsenic trioxide (As 2 O 3 ) as a maintenance therapy for adult T cell leukemia/lymphoma

Retrovirology, 2020-03, Vol.17 (1), p.5-5, Article 5

2020

Link zum Volltext

Verfügbarkeit prüfen

Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study

BMC cancer, 2021-09, Vol.21 (1), p.993-10, Article 993

2021

Link zum Volltext

Verfügbarkeit prüfen

Prognostic impact of translocation t(14;16) in multiple myeloma according to the presence of additional genetic lesions

Blood cancer journal (New York), 2023-10, Vol.13 (1), p.160-160, Article 160

2023

Link zum Volltext

Verfügbarkeit prüfen

Mast cells in spondyloarthritis, more than simple inflammatory bystanders?

Therapeutic advances in musculoskeletal disease, 2020-11, Vol.12, p.1759720-1759720X20971907

2020

Link zum Volltext

Verfügbarkeit prüfen

Recent advances in the understanding and therapeutic management of mastocytosis [version 1; peer review: 4 approved]

F1000 research, 2019, Vol.8, p.1961

2019

Link zum Volltext

Verfügbarkeit prüfen

Mast cells and inflammation

Joint, bone, spine : revue du rhumatisme, 2013-03, Vol.80 (2), p.141-145

2013

Link zum Volltext

Verfügbarkeit prüfen

Actualités du congrès de la Société française d’hématologie (9-11 septembre 2020)

Hématologie, 2020-12, Vol.26 (6), p.298-326

2020

Link zum Volltext

Verfügbarkeit prüfen

Reply to Marhadour et al. regarding their comment about our article entitled “Ivory vertebra and systemic mastocytosis”

Joint, bone, spine : revue du rhumatisme, 2013-10, Vol.80 (5), p.554-554

Frenzel, Laurent

2013

Link zum Volltext

Verfügbarkeit prüfen

Gene therapy for haemophilia A and B, from basic principles to clinical implementation: An illustrated review

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-01, Vol.30 (1), p.5-15

2024

Link zum Volltext

Verfügbarkeit prüfen

A prospective phase 2 trial of daratumumab in patients with previously treated systemic light-chain amyloidosis

Blood, 2020-04, Vol.135 (18), p.1531-1540

2020

Link zum Volltext

Verfügbarkeit prüfen

Prediction of venous thromboembolism in patients with multiple myeloma treated with lenalidomide, bortezomib, dexamethasone, and transplantation: Lessons from the substudy of IFM/DFCI 2009 cohort

Journal of thrombosis and haemostasis, 2022-08, Vol.20 (8), p.1859-1867

2022

Link zum Volltext

Verfügbarkeit prüfen

Emicizumab and asparaginase, A first experience to share

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-03, Vol.30 (2), p.561-563

2024

Link zum Volltext

Verfügbarkeit prüfen

A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML

Leukemia, 2022-11, Vol.36 (11), p.2739-2742

2022

Link zum Volltext

Verfügbarkeit prüfen

Rituximab‐Bendamustine (R‐Benda) in MALT lymphoma complicating primary Sjögren syndrome (pSS)

British journal of haematology, 2019-02, Vol.184 (3), p.472-475

2019

Link zum Volltext

Verfügbarkeit prüfen

Venous thromboembolism prophylaxis and multiple myeloma patients in real-life: Results of a large survey and clinical guidance recommendations from the IFM group

Thrombosis research, 2024-01, Vol.233, p.153-164

2024

Link zum Volltext

Verfügbarkeit prüfen

The effects of time and temperature on the in vitro stability of emicizumab in blood samples: Implications for laboratory and clinical practices

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-03, Vol.30 (2), p.554-557

2024

Link zum Volltext

Verfügbarkeit prüfen

Intraperitoneal bleeding as the initial presentation of Randall-type monoclonal immunoglobulin deposition disease with hepatic involvement

Leukemia & lymphoma, 2021-04, Vol.62 (5), p.1263-1266

2021

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Focus on musculoskeletal health in women with bleeding disorders

Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study

A randomized and double‐blind controlled trial evaluating the safety and efficacy of rituximab for warm auto‐immune hemolytic anemia in adults (the RAIHA study)

Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis

miR-346 controls release of TNF-α protein and stability of its mRNA in rheumatoid arthritis via tristetraprolin stabilization

Bruton's Tyrosine Kinase Is Involved in miR-346-Related Regulation of IL-18 Release by Lipopolysaccharide-Activated Rheumatoid Fibroblast-Like Synoviocytes

Arsenic trioxide (As 2 O 3 ) as a maintenance therapy for adult T cell leukemia/lymphoma

Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study

Prognostic impact of translocation t(14;16) in multiple myeloma according to the presence of additional genetic lesions

Mast cells in spondyloarthritis, more than simple inflammatory bystanders?

Recent advances in the understanding and therapeutic management of mastocytosis [version 1; peer review: 4 approved]

Mast cells and inflammation

Actualités du congrès de la Société française d’hématologie (9-11 septembre 2020)

Reply to Marhadour et al. regarding their comment about our article entitled “Ivory vertebra and systemic mastocytosis”

Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial

Gene therapy for haemophilia A and B, from basic principles to clinical implementation: An illustrated review

A prospective phase 2 trial of daratumumab in patients with previously treated systemic light-chain amyloidosis

Prediction of venous thromboembolism in patients with multiple myeloma treated with lenalidomide, bortezomib, dexamethasone, and transplantation: Lessons from the substudy of IFM/DFCI 2009 cohort

Emicizumab and asparaginase, A first experience to share

A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML

Rituximab‐Bendamustine (R‐Benda) in MALT lymphoma complicating primary Sjögren syndrome (pSS)

Venous thromboembolism prophylaxis and multiple myeloma patients in real-life: Results of a large survey and clinical guidance recommendations from the IFM group

The effects of time and temperature on the in vitro stability of emicizumab in blood samples: Implications for laboratory and clinical practices

Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myélome

Intraperitoneal bleeding as the initial presentation of Randall-type monoclonal immunoglobulin deposition disease with hepatic involvement

Suchergebnisse filtern